ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flu RNA Vaccines Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-35O10570
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Flu RNA Vaccines Market Research Report 2022
BUY CHAPTERS

Global Flu RNA Vaccines Market Research Report 2025

Code: QYRE-Auto-35O10570
Report
February 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur，Inc.
Astrazeneca plc
CSL Limited
Abbott
GlaxoSmithKline PLC
Serum Institute of India Pvt. Ltd
Pfizer Inc
BioNTech
F. Hoffman-La Roche Ltd.
Novartis
Moderna Therapeutics
CureVac
Sinnovac Biotech Ltd

Flu RNA Vaccines Market Size

The global market for Flu RNA Vaccines was valued at US$ 1076 million in the year 2024 and is projected to reach a revised size of US$ 2025 million by 2031, growing at a CAGR of 9.6% during the forecast period.

Flu RNA Vaccines Market

Flu RNA Vaccines Market

Flu RNA Vaccines, commonly known as flu vaccines, are designed to protect against the influenza virus. The influenza virus can cause respiratory illnesses ranging from mild to severe, and vaccination is an effective way to prevent or reduce the severity of flu infections.
Flu RNA Vaccines are an important public health measure to prevent the spread of the influenza virus and reduce the risk of severe illness, hospitalization, and death associated with the flu.
North American market for Flu RNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Flu RNA Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Flu RNA Vaccines include Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech, F.Hoffman La Roche Ltd, Novartis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu RNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu RNA Vaccines.
The Flu RNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Flu RNA Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flu RNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Flu RNA Vaccines Market Report

Report Metric Details
Report Name Flu RNA Vaccines Market
Accounted market size in year US$ 1076 million
Forecasted market size in 2031 US$ 2025 million
CAGR 9.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Non-Replicating mRNA
  • In Vivo Self-Replicating mRNA
  • In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
  • Others
Segment by Application
  • Hospitals
  • Vaccination Center
  • Specialized Clinics
  • Hospital Pharmacy
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech, F.Hoffman La Roche Ltd, Novartis, Sinnovac Biotech Ltd, Moderna Therapeutics, CureVac
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Flu RNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Flu RNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Flu RNA Vaccines Market growing?

Ans: The Flu RNA Vaccines Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the Flu RNA Vaccines Market size in 2031?

Ans: The Flu RNA Vaccines Market size in 2031 will be US$ 2025 million.

Who are the main players in the Flu RNA Vaccines Market report?

Ans: The main players in the Flu RNA Vaccines Market are Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech, F.Hoffman La Roche Ltd, Novartis, Sinnovac Biotech Ltd, Moderna Therapeutics, CureVac

What are the Application segmentation covered in the Flu RNA Vaccines Market report?

Ans: The Applications covered in the Flu RNA Vaccines Market report are Hospitals, Vaccination Center, Specialized Clinics, Hospital Pharmacy, Others

What are the Type segmentation covered in the Flu RNA Vaccines Market report?

Ans: The Types covered in the Flu RNA Vaccines Market report are Non-Replicating mRNA, In Vivo Self-Replicating mRNA, In Vitro Dendritic Cell Non-Replicating mRNA Vaccine, Others

1 Flu RNA Vaccines Market Overview
1.1 Product Definition
1.2 Flu RNA Vaccines by Type
1.2.1 Global Flu RNA Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Non-Replicating mRNA
1.2.3 In Vivo Self-Replicating mRNA
1.2.4 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
1.2.5 Others
1.3 Flu RNA Vaccines by Application
1.3.1 Global Flu RNA Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Vaccination Center
1.3.4 Specialized Clinics
1.3.5 Hospital Pharmacy
1.3.6 Others
1.4 Global Flu RNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global Flu RNA Vaccines Revenue 2020-2031
1.4.2 Global Flu RNA Vaccines Sales 2020-2031
1.4.3 Global Flu RNA Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Flu RNA Vaccines Market Competition by Manufacturers
2.1 Global Flu RNA Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Flu RNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Flu RNA Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Flu RNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flu RNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flu RNA Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Flu RNA Vaccines, Date of Enter into This Industry
2.8 Global Flu RNA Vaccines Market Competitive Situation and Trends
2.8.1 Global Flu RNA Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Flu RNA Vaccines Players Market Share by Revenue
2.8.3 Global Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Flu RNA Vaccines Market Scenario by Region
3.1 Global Flu RNA Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Flu RNA Vaccines Sales by Region: 2020-2031
3.2.1 Global Flu RNA Vaccines Sales by Region: 2020-2025
3.2.2 Global Flu RNA Vaccines Sales by Region: 2026-2031
3.3 Global Flu RNA Vaccines Revenue by Region: 2020-2031
3.3.1 Global Flu RNA Vaccines Revenue by Region: 2020-2025
3.3.2 Global Flu RNA Vaccines Revenue by Region: 2026-2031
3.4 North America Flu RNA Vaccines Market Facts & Figures by Country
3.4.1 North America Flu RNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Flu RNA Vaccines Sales by Country (2020-2031)
3.4.3 North America Flu RNA Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flu RNA Vaccines Market Facts & Figures by Country
3.5.1 Europe Flu RNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Flu RNA Vaccines Sales by Country (2020-2031)
3.5.3 Europe Flu RNA Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flu RNA Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Flu RNA Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Flu RNA Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Flu RNA Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Flu RNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America Flu RNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Flu RNA Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Flu RNA Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flu RNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Flu RNA Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Flu RNA Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Flu RNA Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Flu RNA Vaccines Sales by Type (2020-2031)
4.1.1 Global Flu RNA Vaccines Sales by Type (2020-2025)
4.1.2 Global Flu RNA Vaccines Sales by Type (2026-2031)
4.1.3 Global Flu RNA Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Flu RNA Vaccines Revenue by Type (2020-2031)
4.2.1 Global Flu RNA Vaccines Revenue by Type (2020-2025)
4.2.2 Global Flu RNA Vaccines Revenue by Type (2026-2031)
4.2.3 Global Flu RNA Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Flu RNA Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Flu RNA Vaccines Sales by Application (2020-2031)
5.1.1 Global Flu RNA Vaccines Sales by Application (2020-2025)
5.1.2 Global Flu RNA Vaccines Sales by Application (2026-2031)
5.1.3 Global Flu RNA Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Flu RNA Vaccines Revenue by Application (2020-2031)
5.2.1 Global Flu RNA Vaccines Revenue by Application (2020-2025)
5.2.2 Global Flu RNA Vaccines Revenue by Application (2026-2031)
5.2.3 Global Flu RNA Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Flu RNA Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur Inc.
6.1.1 Sanofi Pasteur Inc. Company Information
6.1.2 Sanofi Pasteur Inc. Description and Business Overview
6.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Inc. Flu RNA Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Inc. Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Flu RNA Vaccines Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 CSL Ltd.
6.3.1 CSL Ltd. Company Information
6.3.2 CSL Ltd. Description and Business Overview
6.3.3 CSL Ltd. Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Ltd. Flu RNA Vaccines Product Portfolio
6.3.5 CSL Ltd. Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Company Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Flu RNA Vaccines Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline Plc.
6.5.1 GlaxoSmithKline Plc. Company Information
6.5.2 GlaxoSmithKline Plc. Description and Business Overview
6.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Plc. Flu RNA Vaccines Product Portfolio
6.5.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.6 Serum Institute of India Pvt. Ltd.
6.6.1 Serum Institute of India Pvt. Ltd. Company Information
6.6.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product Portfolio
6.6.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Flu RNA Vaccines Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 BioNTech
6.8.1 BioNTech Company Information
6.8.2 BioNTech Description and Business Overview
6.8.3 BioNTech Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioNTech Flu RNA Vaccines Product Portfolio
6.8.5 BioNTech Recent Developments/Updates
6.9 F.Hoffman La Roche Ltd
6.9.1 F.Hoffman La Roche Ltd Company Information
6.9.2 F.Hoffman La Roche Ltd Description and Business Overview
6.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 F.Hoffman La Roche Ltd Flu RNA Vaccines Product Portfolio
6.9.5 F.Hoffman La Roche Ltd Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Flu RNA Vaccines Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Sinnovac Biotech Ltd
6.11.1 Sinnovac Biotech Ltd Company Information
6.11.2 Sinnovac Biotech Ltd Description and Business Overview
6.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sinnovac Biotech Ltd Flu RNA Vaccines Product Portfolio
6.11.5 Sinnovac Biotech Ltd Recent Developments/Updates
6.12 Moderna Therapeutics
6.12.1 Moderna Therapeutics Company Information
6.12.2 Moderna Therapeutics Description and Business Overview
6.12.3 Moderna Therapeutics Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Moderna Therapeutics Flu RNA Vaccines Product Portfolio
6.12.5 Moderna Therapeutics Recent Developments/Updates
6.13 CureVac
6.13.1 CureVac Company Information
6.13.2 CureVac Description and Business Overview
6.13.3 CureVac Flu RNA Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CureVac Flu RNA Vaccines Product Portfolio
6.13.5 CureVac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flu RNA Vaccines Industry Chain Analysis
7.2 Flu RNA Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flu RNA Vaccines Production Mode & Process Analysis
7.4 Flu RNA Vaccines Sales and Marketing
7.4.1 Flu RNA Vaccines Sales Channels
7.4.2 Flu RNA Vaccines Distributors
7.5 Flu RNA Vaccines Customer Analysis
8 Flu RNA Vaccines Market Dynamics
8.1 Flu RNA Vaccines Industry Trends
8.2 Flu RNA Vaccines Market Drivers
8.3 Flu RNA Vaccines Market Challenges
8.4 Flu RNA Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur，Inc.
Astrazeneca plc
CSL Limited
Abbott
GlaxoSmithKline PLC
Serum Institute of India Pvt. Ltd
Pfizer Inc
BioNTech
F. Hoffman-La Roche Ltd.
Novartis
Moderna Therapeutics
CureVac
Sinnovac Biotech Ltd
List of Tables
 Table 1. Global Flu RNA Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Flu RNA Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Flu RNA Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Flu RNA Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Flu RNA Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Flu RNA Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Flu RNA Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Flu RNA Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Flu RNA Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Flu RNA Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Flu RNA Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Flu RNA Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Flu RNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu RNA Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Flu RNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Flu RNA Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Flu RNA Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Flu RNA Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Flu RNA Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Flu RNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Flu RNA Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Flu RNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Flu RNA Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Flu RNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Flu RNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Flu RNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Flu RNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Flu RNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Flu RNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Flu RNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Flu RNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Flu RNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Flu RNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Flu RNA Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Flu RNA Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Flu RNA Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Flu RNA Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Flu RNA Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Flu RNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Flu RNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Flu RNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Flu RNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Flu RNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Flu RNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Flu RNA Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Flu RNA Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Flu RNA Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Flu RNA Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Flu RNA Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Flu RNA Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Flu RNA Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Flu RNA Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Flu RNA Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Flu RNA Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Flu RNA Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Flu RNA Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Flu RNA Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Flu RNA Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Flu RNA Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Flu RNA Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Flu RNA Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Flu RNA Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Flu RNA Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Flu RNA Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Flu RNA Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Flu RNA Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Flu RNA Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Flu RNA Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Pasteur Inc. Company Information
 Table 71. Sanofi Pasteur Inc. Description and Business Overview
 Table 72. Sanofi Pasteur Inc. Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur Inc. Flu RNA Vaccines Product
 Table 74. Sanofi Pasteur Inc. Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca Flu RNA Vaccines Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. CSL Ltd. Company Information
 Table 81. CSL Ltd. Description and Business Overview
 Table 82. CSL Ltd. Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CSL Ltd. Flu RNA Vaccines Product
 Table 84. CSL Ltd. Recent Developments/Updates
 Table 85. Abbott Company Information
 Table 86. Abbott Description and Business Overview
 Table 87. Abbott Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Abbott Flu RNA Vaccines Product
 Table 89. Abbott Recent Developments/Updates
 Table 90. GlaxoSmithKline Plc. Company Information
 Table 91. GlaxoSmithKline Plc. Description and Business Overview
 Table 92. GlaxoSmithKline Plc. Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Plc. Flu RNA Vaccines Product
 Table 94. GlaxoSmithKline Plc. Recent Developments/Updates
 Table 95. Serum Institute of India Pvt. Ltd. Company Information
 Table 96. Serum Institute of India Pvt. Ltd. Description and Business Overview
 Table 97. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product
 Table 99. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Flu RNA Vaccines Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. BioNTech Company Information
 Table 106. BioNTech Description and Business Overview
 Table 107. BioNTech Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BioNTech Flu RNA Vaccines Product
 Table 109. BioNTech Recent Developments/Updates
 Table 110. F.Hoffman La Roche Ltd Company Information
 Table 111. F.Hoffman La Roche Ltd Description and Business Overview
 Table 112. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. F.Hoffman La Roche Ltd Flu RNA Vaccines Product
 Table 114. F.Hoffman La Roche Ltd Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis Flu RNA Vaccines Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Sinnovac Biotech Ltd Company Information
 Table 121. Sinnovac Biotech Ltd Description and Business Overview
 Table 122. Sinnovac Biotech Ltd Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sinnovac Biotech Ltd Flu RNA Vaccines Product
 Table 124. Sinnovac Biotech Ltd Recent Developments/Updates
 Table 125. Moderna Therapeutics Company Information
 Table 126. Moderna Therapeutics Description and Business Overview
 Table 127. Moderna Therapeutics Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Moderna Therapeutics Flu RNA Vaccines Product
 Table 129. Moderna Therapeutics Recent Developments/Updates
 Table 130. CureVac Company Information
 Table 131. CureVac Description and Business Overview
 Table 132. CureVac Flu RNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. CureVac Flu RNA Vaccines Product
 Table 134. CureVac Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Flu RNA Vaccines Distributors List
 Table 138. Flu RNA Vaccines Customers List
 Table 139. Flu RNA Vaccines Market Trends
 Table 140. Flu RNA Vaccines Market Drivers
 Table 141. Flu RNA Vaccines Market Challenges
 Table 142. Flu RNA Vaccines Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Flu RNA Vaccines
 Figure 2. Global Flu RNA Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Flu RNA Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Non-Replicating mRNA Product Picture
 Figure 5. In Vivo Self-Replicating mRNA Product Picture
 Figure 6. In Vitro Dendritic Cell Non-Replicating mRNA Vaccine Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Flu RNA Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Flu RNA Vaccines Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Vaccination Center
 Figure 12. Specialized Clinics
 Figure 13. Hospital Pharmacy
 Figure 14. Others
 Figure 15. Global Flu RNA Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Flu RNA Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Flu RNA Vaccines Sales (2020-2031) & (K Units)
 Figure 18. Global Flu RNA Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 19. Flu RNA Vaccines Report Years Considered
 Figure 20. Flu RNA Vaccines Sales Share by Manufacturers in 2024
 Figure 21. Global Flu RNA Vaccines Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Flu RNA Vaccines Players: Market Share by Revenue in Flu RNA Vaccines in 2024
 Figure 23. Flu RNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Flu RNA Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Flu RNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. North America Flu RNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Flu RNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 30. Europe Flu RNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Flu RNA Vaccines Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Flu RNA Vaccines Revenue Market Share by Region (2020-2031)
 Figure 38. China Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Flu RNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Flu RNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Flu RNA Vaccines Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Flu RNA Vaccines Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. U.A.E Flu RNA Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Flu RNA Vaccines by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Flu RNA Vaccines by Type (2020-2031)
 Figure 60. Global Flu RNA Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Flu RNA Vaccines by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Flu RNA Vaccines by Application (2020-2031)
 Figure 63. Global Flu RNA Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 64. Flu RNA Vaccines Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions